TABLE 3

wT-Weighted Equivalent Organ Doses, Absorbed Doses, and LAR Values for Two 32-kg Pediatric Patients for 99mTc-DMSA Renal Imaging Studies

Short, stout (fifth bin 90th percentile, 125-cm height)Tall, thin (seventh bin 10th percentile; 147-cm height)
LAR*LAR†
Target organwT H(rT)/A0 (mSv/MBq)D(rT)/A0 (mGy/MBq)10-y-old girlSex- and age-averagedwT H(rT)/A0 (mSv/MBq)D(rT)/A0 (mGy/MBq)10-y-old girlSex- and age-averaged
Colon7.81E–046.51E–030.60.54.94E–044.12E–030.20.2
Lungs1.86E–031.55E–024.62.21.45E–031.21E–021.80.9
Stomach wall2.16E–041.80E–030.10.01.52E–041.27E–030.00.0
Ovaries3.79E–064.74E–050.00.03.74E–064.68E–050.00.0
Urinary bladder wall2.57E–056.43E–040.10.02.16E–055.40E–040.00.0
Esophagus9.22E–062.31E–04––5.40E–061.35E–04––
Liver2.97E–037.43E–020.90.92.16E–035.40E–020.30.3
Brain6.53E–066.53E–04––1.59E–051.59E–03––
Salivary glands3.85E–073.85E–05––1.10E–061.10E–04––
Skin1.28E–041.28E–02––9.97E–059.97E–03––
Remainder7.57E–036.31E–02––4.96E–034.13E–02––
Red bone marrow5.26E–044.38E–030.20.24.09E–043.41E–030.10.1
Endosteum9.22E–059.22E–03––7.18E–057.18E–03––
Effective dose1.42E–029.84E–03

  • ↵* No. of excess cancer incidence cases for population of 100,000 receiving AA of 1.85 MBq/kg (=59.2 MBq).

  • ↵† No. of excess cancer incidence cases for a population of 100,000 receiving AA of 0.93 MBq/kg (=29.6 MBq)